TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent to U.S. and European reference Apixaban tablets...
Hence then, the article about taho pharmaceuticals reports positive results from pivotal study of tah3311 the first oral dissolving film anticoagulant was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant )
Also on site :
- Johnny Knoxville Takes Credit For “Monstrous Explosion” In Simi Valley During ‘Jackass: Best and Last’ Wrap
- Indigo Girls’ Emily Saliers Reveals Cervical Dystonia and Essential Tremor Diagnoses: ‘My Voice Will Not Be What It Was’
- SK hynix Begins Mass Production of 192GB SOCAMM2 'Setting a New Standard for AI Server Memory Performance'